Mount Sinai ADRC: Core Satellite (Neugroschl) | PROJECT SUMMARY The overarching goal of the Satellite Core is to ensure that the Mount Sinai Alzheimer's Disease Research Center (MSADRC) has an adequate representation of minorities, particularly Latinos, as they are the predominant Underrepresented Group in our local community, and are at greater risk for dementia. Our innovative outreach programs, based on community based participatory research methodology, coupled with our flexible strategy for doing research evaluations, have made this core successful. The Satellite Core is committed to building bridges with this underserved, under represented community, to foster trust. In the upcoming cycle, we will continue to disseminate culturally and linguistically appropriate information about cognition, diabetes and dementia, and to incorporate feedback from the community to tailor outreach and recruitment efforts. We will achieve this goal by using evidence-based methods based on our research and knowledge of the neuropsychological and medical profiles of this demographic, to accurately diagnose the individuals that come into our center. We work with the Outreach Recruitment and Education (ORE) Core to disseminate information and translate new knowledge to health professionals, trainees and the lay community. The Satellite Core is responsible for the recruitment and retention of Latino participants for the MSADRC Clinical Core, to comprehensively characterize these subjects and to facilitate participation in biomarker collection and other clinical studies. The activities of the Satellite Core represent a collaborative effort involving close participation with the ORE Core and the Clinical Core and the Administrative Core, as well as a partnership with the New York State funded Alzheimer's Disease Assistance Center (ADAC). Working together, through numerous community outreach efforts including surveys and focus groups, we have been able to identify cultural barriers participation to research to create a network of community partnerships. Our Satellite Core efforts are integrated into the Clinical Core, but allow for additional community based and home based testing, effectively making it a Satellite without Walls. This strong foundation for the recruitment and retention of culturally diverse participants, allows for successful recruitment of Latino subjects, and we look forward to reaching out to other Mount Sinai communities (for example Mount Sinai Beth Israel) to expand our efforts. We have made contributions to National Alzheimer's Project Act (NAPA)'s primary goal to prevent and effectively treat AD by 2025 by increasing participation of Latinos in clinical studies, in helping to meaningfully characterize this population to facilitate the assessment and diagnosis of these individuals.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
2P50AG005138-31
Application #
8849214
Study Section
Special Emphasis Panel (ZAG1-ZIJ-5 (J1))
Project Start
Project End
Budget Start
2015-05-01
Budget End
2016-03-31
Support Year
31
Fiscal Year
2015
Total Cost
$124,705
Indirect Cost
Name
Icahn School of Medicine at Mount Sinai
Department
Type
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Gandal, Michael J; Haney, Jillian R; Parikshak, Neelroop N et al. (2018) Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap. Science 359:693-697
Barnes, Josephine; Bartlett, Jonathan W; Wolk, David A et al. (2018) Disease Course Varies According to Age and Symptom Length in Alzheimer's Disease. J Alzheimers Dis 64:631-642
Schaffert, Jeff; LoBue, Christian; White, Charles L et al. (2018) Traumatic brain injury history is associated with an earlier age of dementia onset in autopsy-confirmed Alzheimer's disease. Neuropsychology 32:410-416
Huckins, L M; Hatzikotoulas, K; Southam, L et al. (2018) Investigation of common, low-frequency and rare genome-wide variation in anorexia nervosa. Mol Psychiatry 23:1169-1180
Soleimani, Laili; Ravona-Springer, Ramit; Heymann, Anthony et al. (2018) Depression is more strongly associated with cognition in elderly women than men with type 2 diabetes. Int Psychogeriatr :1-5
Ki?emet-Piska?, Spomenka; Babi? Leko, Mirjana; Blažekovi?, Antonela et al. (2018) Evaluation of cerebrospinal fluid phosphorylated tau231 as a biomarker in the differential diagnosis of Alzheimer's disease and vascular dementia. CNS Neurosci Ther 24:734-740
Audrain, Mickael; Haure-Mirande, Jean-Vianney; Wang, Minghui et al. (2018) Integrative approach to sporadic Alzheimer's disease: deficiency of TYROBP in a tauopathy mouse model reduces C1q and normalizes clinical phenotype while increasing spread and state of phosphorylation of tau. Mol Psychiatry :
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2018) Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry 33:200-211
Zhu, Carolyn W; Grossman, Hillel; Neugroschl, Judith et al. (2018) A randomized, double-blind, placebo-controlled trial of resveratrol with glucose and malate (RGM) to slow the progression of Alzheimer's disease: A pilot study. Alzheimers Dement (N Y) 4:609-616
Boban, Mirta; Babi? Leko, Mirjana; Miški?, Terezija et al. (2018) Human neuroblastoma SH-SY5Y cells treated with okadaic acid express phosphorylated high molecular weight tau-immunoreactive protein species. J Neurosci Methods :

Showing the most recent 10 out of 555 publications